| |
|
|
|
Forward Pharma Ads  
|
|
6.57 0.03 (0%) |
01-25 16:00 |
|
Open: |
6.66 |
Pre close: |
6.54 |
Target:
|
8.78
|
|
High: |
6.66 |
Low: |
6.52 |
Resistance:
|
7.52
8.19
|
|
Volume: |
12,936 |
Market Cap: |
45M |
Support:
|
6.43
5.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.58
 |
MACD |
MACD(12,26):
|
-0.16  |
|
MA(20): |
7.11 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
6.69 |
Stochastic Oscillator |
%K(14,3):
|
7.58 |
|
MA(250): |
6.47 |
%D(3): |
7.95 |
|
Average Volume(K) |
3-Month: |
2383
|
52-Week |
High:
|
12.72 |
|
10-Days: |
3555 |
Low: |
4.61 |
|
RSI |
RSI(14):
|
38.22 |
Change(%): |
0.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.490 |
Return on Equity (ttm) |
-4.7 |
Shares Out. (M) |
6.89 |
|
EPS Est. Current Year |
2.490 |
Return on Assets (ttm) |
-3.3 |
Shares Float (M) |
1.33 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.830 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.57 |
|
Forward EPS |
-0.090 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5 |
|
Book Value (p.s.) |
9.360 |
EBITDA (p.s.) |
-0.592 |
P/E |
-13.41 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.70 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
